Aug 7, 2025 07:53AM Collegium Pharma (COLL) Tops Q2 EPS by 2c ; Offers Guidance

Jul 7, 2025 08:00AM Collegium pharmaceutical authorizes $150 million share buyback program

May 12, 2025 11:36AM Truist Lays Out Prelim Thoughts on Impact to Generic Drugs Amid WH Update on Drug Pricing

May 12, 2025 08:05AM Collegium Pharma (COLL) Announces $25M Accelerated Share Buyback

Mar 26, 2025 07:02AM Avalo Therapuetics (AVTX) Appoints Michael Heffernan as Chairman of the Board

Mar 24, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Collegium Pharmaceutical (COLL)

Mar 17, 2025 07:02AM Collegium Pharma (COLL) Announces Updates to its Board of Directors and Executive Leadership Team

Feb 27, 2025 04:35PM Collegium Pharma (COLL) Tops Q4 EPS by 9c, provides guidance

Feb 5, 2025 08:02AM Collegium Pharma (COLL) Appoints Nancy S. Lurker to its Board

Feb 4, 2025 07:03AM Collegium Pharmaceutical (COLL) PT Lowered to $36 at Piper Sandler

Jan 8, 2025 08:03AM Collegium Pharma (COLL) Provides 2025 Financial Guidance and Business Update

Nov 11, 2024 03:55PM Collegium Pharmaceutical (COLL) PT Lowered to $40 at Jefferies

Nov 7, 2024 04:55PM Collegium Pharma (COLL) Tops Q3 EPS by 4c

Nov 7, 2024 04:02PM Collegium Pharma (COLL) Appoints Vikram Karnani as CEO

Oct 11, 2024 08:00AM Piper Sandler Reiterates Neutral Rating on Collegium Pharmaceutical (COLL)

Sep 5, 2024 06:36AM Collegium Pharmaceutical (COLL) PT Raised to $50 at H.C. Wainwright

Aug 9, 2024 09:15AM Collegium Pharmaceutical (COLL) PT Lowered to $37 at Piper Sandler

Aug 8, 2024 04:08PM Collegium Pharma (COLL) Misses Q2 EPS by 3c, provides guidance

Jun 13, 2024 08:02AM Collegium Pharma (COLL) Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise